These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28759021)

  • 1. ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma.
    Marshall AD; van Geldermalsen M; Otte NJ; Lum T; Vellozzi M; Thoeng A; Pang A; Nagarajah R; Zhang B; Wang Q; Anderson L; Rasko JEJ; Holst J
    Oncogenesis; 2017 Jul; 6(7):e367. PubMed ID: 28759021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells.
    Bröer A; Rahimi F; Bröer S
    J Biol Chem; 2016 Jun; 291(25):13194-205. PubMed ID: 27129276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
    van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
    Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
    Marshall AD; van Geldermalsen M; Otte NJ; Anderson LA; Lum T; Vellozzi MA; Zhang BK; Thoeng A; Wang Q; Rasko JE; Holst J
    Int J Cancer; 2016 Dec; 139(11):2529-39. PubMed ID: 27486861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of the
    Bröer A; Gauthier-Coles G; Rahimi F; van Geldermalsen M; Dorsch D; Wegener A; Holst J; Bröer S
    J Biol Chem; 2019 Mar; 294(11):4012-4026. PubMed ID: 30635397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
    Wang Q; Hardie RA; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJ; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J
    J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
    Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
    Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone inhibits endometrial cancer growth by inhibiting glutamine metabolism through ASCT2.
    Guo J; Fan J; Zhang Y; Li M; Jin Z; Shang Y; Zhang H; Kong Y
    Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38415405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth.
    Ye J; Huang Q; Xu J; Huang J; Wang J; Zhong W; Chen W; Lin X; Lin X
    J Cancer Res Clin Oncol; 2018 May; 144(5):821-833. PubMed ID: 29435734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
    Lu H; Li X; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Oct; 381(1):23-30. PubMed ID: 27450723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
    Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity glutamate transporter GLAST/EAAT1 regulates cell surface expression of glutamine/neutral amino acid transporter ASCT2 in human fetal astrocytes.
    Gegelashvili M; Rodriguez-Kern A; Pirozhkova I; Zhang J; Sung L; Gegelashvili G
    Neurochem Int; 2006; 48(6-7):611-5. PubMed ID: 16516348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASCT2-mediated glutamine uptake promotes Th1 differentiation via ROS-EGR1-PAC1 pathway in oral lichen planus.
    Li W; Ling Z; Wang J; Su Z; Lu J; Yang X; Cheng B; Tao X
    Biochem Pharmacol; 2023 Oct; 216():115767. PubMed ID: 37634599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric Cancer.
    Ma H; Wu J; Zhou M; Wu J; Wu Z; Lin L; Huang N; Liao W; Sun L
    Integr Cancer Ther; 2021; 20():15347354211045349. PubMed ID: 34590499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer.
    Wahi K; Freidman N; Wang Q; Devadason M; Quek LE; Pang A; Lloyd L; Larance M; Zanini F; Harvey K; O'Toole S; Guan YF; Holst J
    EMBO J; 2024 Oct; ():. PubMed ID: 39420093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular identification and characterisation of the glycine transporter (GLYT1) and the glutamine/glutamate transporter (ASCT2) in the rat lens.
    Lim J; Lorentzen KA; Kistler J; Donaldson PJ
    Exp Eye Res; 2006 Aug; 83(2):447-55. PubMed ID: 16635486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets.
    Bröer A; Fairweather S; Bröer S
    Front Pharmacol; 2018; 9():785. PubMed ID: 30072900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells.
    Fuchs BC; Perez JC; Suetterlin JE; Chaudhry SB; Bode BP
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G467-78. PubMed ID: 14563674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamine availability up-regulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter.
    Bungard CI; McGivan JD
    Biochem J; 2004 Aug; 382(Pt 1):27-32. PubMed ID: 15175006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2.
    Zhou P; Liang X; Zhou C; Qin J; Hou C; Zhu Z; Zhang W; Wang S; Zhong D
    J Mater Chem B; 2019 Sep; 7(35):5363-5375. PubMed ID: 31403158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.